Search Within


What is the Best Option to Cure Patients with Resistant/Relapsing Hodgkins Disease?

Journal: Current Stem Cell Research & Therapy
Volume: 1, Issue: 3
Page: 419-424
Authors: Massimo Magagnoli, Monica Balzarotti, Luca Castagna, Monica Demarco and Armando Santoro

Nuclear Factor-κB: A Holy Grail in Cancer Prevention and Therapy

Journal: Current Signal Transduction Therapy
Volume: 1, Issue: 1
Page: 25-52
Authors: Bharat B. Aggarwal, Gautam Sethi, Asha Nair and Haruyo Ichikawa

Angiogenesis in Lymphoma: A Short Review

Journal: Current Molecular Medicine
Volume: 5, Issue: 7
Page: 609-613
Authors: Anas Younes

CD4+ T Cell Responses in the Immune Control Against Latent Infection by Epstein-Barr Virus

Journal: Current Molecular Medicine
Volume: 3, Issue: 4
Page: 341-347
Authors: Casper Paludan and Christian Munz

Novel Virally Targeted Therapies of EBV-Associated Tumors

Journal: Current Cancer Drug Targets
Volume: 8, Issue: 7
Page: 581-596
Authors: Paolo De Paoli

Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

Journal: Current Pharmaceutical Design
Volume: 15, Issue: 23
Page: 2652-2664
Authors: Robert J. Kreitman